Sort
46,585 grants matching “heart failure”
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
$524,517Bruce R Conklin · J. David Gladstone Institutes · R01 · FY2020 · HL
Molecular control of ischemia-induced tissue fibrosis
$524,517Jun Yu · Temple Univ Of The Commonwealth · R01 · FY2022 · HL
Molecular control of ischemia-induced tissue fibrosis
$524,517Jun Yu · Temple Univ Of The Commonwealth · R01 · FY2021 · HL
Regenerative Therapies for Inherited Blood Disorders-iPSC differentiation
$524,511Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Role of Cardiac Myosin Binding Protein-C in the Regulation of Myocardial Contraction
$524,508Samantha P Harris · University Of Arizona · R01 · FY2018 · HL
Proteolytic Regulation of Troponin T & Cardiac Function
$524,400Jian-Ping Jin · Wayne State University · R01 · FY2011 · HL
Pathophysiology of Heart Failure with a Normal Ejection Fraction in the Elderly
$524,350Mathew S Maurer · Columbia University Health Sciences · R01 · FY2009 · AG
Prevention of anthracycline-induced cardiotoxicity by Nur77 activation
$524,331Jianxin Sun · Thomas Jefferson University · R01 · FY2023 · HL
The role of REDD1 in insulin-mediated transcription
$524,241Jessica Pfleger Karch · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · HL
Mental Health Spending and Quality of Care
$524,222Richard Gabriel Frank · Harvard Medical School · R01 · FY2010 · MH
Integrating multi-omics data to understand the heterogeneity of preeclampsia and long-termpostpartum hypertension
$524,179Nathan Richard Blue · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL
Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathy
$524,177Luisa Mestroni · University Of Colorado Denver · R01 · FY2020 · HL
Reducing cardiac toxicity with deep learning and MRI-guided radiation therapy
$524,106Carri Kaye Glide-Hurst · University Of Wisconsin-Madison · R01 · FY2021 · HL
Integrative Mechanisms in Cardiovascular Disease
$524,078Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School · T32 · FY2007 · HL
Integrative Mechanisms in Cardiovascular Disease
$524,078Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School · T32 · FY2006 · HL
Novel Strategy of PDE5-mTOR Inhibition in Attenuation of Cancer Drug Cardiotoxicity
$524,060Anindita Das · Virginia Commonwealth University · R01 · FY2025 · HL
Study of Osteoporotic Fractures
$524,002Kristine Ensrud · University Of Minnesota · R01 · FY2012 · AG
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)
$523,979Joachim H Ix · Veterans Medical Research Fdn/San Diego · U01 · FY2023 · DK
The Role of TGF-beta Activation and Signaling in Aortic Stenosis Progression
$523,846Jasimuddin Ahamed · Oklahoma Medical Research Foundation · R01 · FY2020 · HL
The Role of TGF-beta Activation and Signaling in Aortic Stenosis Progression
$523,846Jasimuddin Ahamed · Oklahoma Medical Research Foundation · R01 · FY2021 · HL
SKNA as a biomarker for cardiovascular events
$523,816Thomas H Everett · Indiana University Indianapolis · R01 · FY2022 · HL
Role of cyclic nucleotide signaling in aortic aneurysm
$523,805Chen Yan · University Of Rochester · R01 · FY2024 · HL
Predicting ECMO NeuroLogICal Injuries using mAchiNe Learning (PELICAN)
$523,509Lakshmi Raman · Ut Southwestern Medical Center · R01 · FY2025 · NS
The ENIGMA - Eating Disorders Initiative: A Global Neuroimaging Study of Anorexia and Factors Affecting Clinical Outcomes
$523,499Paul M Thompson · University Of Southern California · U01 · FY2025 · MH
Trends in and Outcomes of Medication Use in Older Adults
$523,496University Of Washington · R01 · FY2004 · AG